Page last updated: 2024-08-21

pyrimidine and B-Cell Leukemia

pyrimidine has been researched along with B-Cell Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, X; Li, Y; Liu, H; Liu, K; Ma, X; Peng, J; Qu, M; Shu, X; Wang, C; Xu, L; Yao, J	1

Other Studies

1 other study(ies) available for pyrimidine and B-Cell Leukemia

Article	Year
Design and synthesis of sulfonamide-substituted diphenylpyrimidines (SFA-DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors with improved activity toward B-cell lymphoblastic leukemia. European journal of medicinal chemistry, 2017, Jul-28, Volume: 135 Topics: Agammaglobulinaemia Tyrosine Kinase; Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Humans; Leukemia, B-Cell; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Structure-Activity Relationship; Sulfonamides	2017

Article

Year

Design and synthesis of sulfonamide-substituted diphenylpyrimidines (SFA-DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors with improved activity toward B-cell lymphoblastic leukemia.

European journal of medicinal chemistry, 2017, Jul-28, Volume: 135

Topics: Agammaglobulinaemia Tyrosine Kinase; Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Humans; Leukemia, B-Cell; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Structure-Activity Relationship; Sulfonamides

2017